Genetic diversity and molecular epidemiology of human rhinoviruses in South Africa

Marthi Pretorius(National Health Laboratory Service), Marietjie Venter(University of the Witwatersrand), Jocelyn Moyes(University of the Witwatersrand), Adam L. Cohen(Centers for Disease Control and Prevention), Sumayya Haffjee(Metropolitan Hospital Center), Sibongile Walaza(National Health Laboratory Service), Shabir A. Madhi(University of the Witwatersrand), Florette K. Treurnicht(National Health Laboratory Service), Stefano Tempia(Centers for Disease Control and Prevention), Ebrahim Variava(Kalafong Hospital), Cheryl Cohen(University of the Witwatersrand), Halima Dawood(Centre for the AIDS Programme of Research in South Africa), Meera Chhagan(Metropolitan Hospital Center), Orienka Hellferscee
Influenza and Other Respiratory Viruses
July 3, 2014
10.1111/irv.12264
Cited by 23

Related Papers

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
|The Lancet|2020|5k
Estimates of global seasonal influenza-associated respiratory mortality: a modelling study
|The Lancet|2017|3.1k
Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study
|The Lancet|2017|2.4k
Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials
|The Lancet|2021|1.2k
SARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses
|Cell|2022|1k